Lifeboat Foundation

Rapamycin could lead to the development of drugs to delay some aspects of aging in particular the immune systems decline with age.

Nearly a decade of research showing that Rapamycin makes mice live up to 60% longer, scientists are trying it out as an anti-aging drug in dogs and humans.

Researchers at the University of Washington’s Dog Aging Project gave rapamycin to 16 dogs and imaged their hearts.

Continue reading “Side Effects of Antiaging drug Rapamycin can be managed with lower doses and appears to improve the immune system, restore vitality and delay heart disease and dementia” »

Circa News, a millennial site, did a story on transhumanism and my campaign. There are 3 videos embedded into this article (a general one on transhumanism, one on using tech to help the environment, and one on a Universal Basic Income):

WATCH | Zoltan Istvan thinks all sentient beings — including, but not limited to humans, artificial intelligence and cyborgs — have the right to be immortal. And that right should be protected under law.

Which is why, naturally, he decided to run for president of the United States.

Continue reading “Meet the 2016 presidential candidate who believes humans will eventually live forever” »

In Brief.

• New research concludes that human lifespan has already reached its peak of 125 years.
• The research does not take into account synthetic biology and advancements in biotech that could extend lifespans further.

Scientists at the Albert Einstein College of Medicine assert that they have discovered the maximum lifespan of human beings, and it’s a range we may no longer be able to exceed. Dr. Jan Vijg, professor of ophthalmology and visual sciences at Einstein, lead the research, which was published online today in the journal Nature.

Scientific progress is being held back by established experts who lack ambition and vision.

The mainstream of aging research, at least in public, is characterized by a profound lack of ambition when it comes to treating aging as a medical condition. Researchers talk about slightly altering the trajectory of aging as though that is the absolute most that is possible, the summit of the mountain, and are in many cases ambivalent when it comes to advocating for even that minimal goal. It is this state of affairs that drove Aubrey de Grey and others into taking up advocacy and research, given that there are clear paths ahead to rejuvenation, not just a slight slowing of aging, but halting and reversing the causes of aging. Arguably embracing rejuvenation research programs would in addition cost less and take a much shorter span of time to produce results, since these programs are far more comprehensively mapped out than are efforts to produce drugs to alter the complex operations of metabolism so as to slightly slow the pace at which aging progresses. It is most frustrating to live in a world in which this possibility exists, yet is still a minority concern in the research community. This article is an example of the problem, in which an eminent researcher in the field takes a look at a few recently published books on aging research, and along the way reveals much about his own views on aging as an aspect of the human condition that needs little in the way of a solution. It is a terrible thing that people of this ilk are running the institutes and the funding bodies: this is a field crying out for disruption and revolution in the name of faster progress towards an end to aging.

Quote:

Continue reading “An Example of the Glaring Lack of Ambition in Aging Research” »

Time to reimagine aging.

Continue reading “Lifespan.io / Life Extension Advocacy Foundation” »

Classifying aging as a disease, the debate is hotting up as ICD11 at WHO draws near.

What is considered to be normal and what is considered to be diseased is strongly influenced by historical context (Moody, 2001/2002). Matters once considered to be diseases are no longer classified as such. For example, when black slaves ran away from plantations they were labeled to suffer from drapetomania and medical treatment was used to try to “cure” them (Reznek, 1987). Similarly, masturbation was seen as a disease and treated with treatments such as cutting away the clitoris or cauterizing it (Reznek, 1987). Finally, homosexuality was considered a disease as recently as 1974 (Reznek, 1987). In addition to the social and cultural influence on disease definition, new scientific and medical discoveries lead to the revision of what is a disease and what is not (Butler, 2008). For example, fever was once seen as a disease in its own right but the realization that different underlying causes would lead to the appearance of fever changed its status from disease to symptom (Reznek, 1987). Conversely, several currently recognized diseases, such as osteoporosis, isolated systolic hypertension, and senile Alzheimer’s disease, were in the past ascribed to normal aging (Izaks and Westendorp, 2003; Gems, 2011). Osteoporosis was only officially recognized as a disease in 1994 by the World Health Organization (WHO, 1994).

Go to:

Continue reading “It is time to classify biological aging as a disease” »

How society can profit from treating age-related diseases.

We’re now living longer than ever – only to suffer from diseases of old age. New therapies promise a new lease of life for the elderly – and big profits for investors, says Matthew Partridge.

Over the past century, average life expectancy in most countries has grown substantially. Vastly lower infant mortality, improved living standards, better public sanitation, and the discovery of cures or vaccines for many once-deadly diseases, have seen average life expectancy in most developed nations rise to around 80, compared with 50 in 1900. Developing nations have benefited too. Life expectancy in China, for example, was just 43 in 1960 – it’s 75 today. Indeed, according to the World Health Organisation, no individual nation outside Africa now has a life expectancy of below 60, and even Africa has seen huge gains since 2000, helped by improved anti-malarial measures and wider availability of HIV/Aids treatments.

Continue reading “How we can profit from winning the battle against ageing” »

Pesquisadores da Human Longevity, Inc. Publicou documentos detalhando resultados do sequenciamento profundo de 10.545 genomas humanos.

Documento descreve 150 milhões de variantes raras ou desconhecidas; cerca de 8.500 novas variantes por genoma.

Companhia também anuncia novo motor de pesquisa do genoma, HLI Open Search, para testes beta.

Continue reading “Transhumanismo Brasil” »

My new story for TechCrunch on why a new generation of kids might “really” love robots. What would Freud say?

Robots intrigue us. We all like them. But most of us don’t love them. That may dramatically change over the next 10 years as the “robot nanny” makes its way into our households.

In as little time as a decade, affordable robots that can bottle-feed babies, change diapers and put a child to sleep might be here. The human-machine bond that a new generation of kids grows up with may be unbreakable. We may end up literally loving our machines almost like we do our mothers and fathers.

Continue reading “What Are the Absolute Worst Cities to Work in Right Now?” »